The FDA warned a manufacturer of skin-care drug products in The Philippines for significant GMP violations. Source: Drug Industry Daily

In a citizen petition, the Wilson Disease Association asked the FDA to approve two ANDAs from Kadmon Holdings for generic trientine. Source: Drug Industry Daily

U.S. Bioservices will pay $13.4 million to settle a lawsuit concerning allegations the company illegally billed federal and state insurers for prescriptions for Novartis AG’s Exjade in exchange for referrals…

The FDA has agreed to fully share information from its inspections of drug manufacturers with its European Union counterparts, including for the first time trade secrets, the agencies announced. Source:…